Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SVB Leerink Maintains Outperform on Roivant Sciences, Raises Price Target to $10

SVB Leerink analyst David Risinger maintains Roivant Sciences (NASDAQ:ROIV) with a Outperform and raises the price target from $8 to $10.
byBenzinga Newsdesk
December 19, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

SVB Leerink analyst David Risinger maintains Roivant Sciences (NASDAQ:ROIV) with a Outperform and raises the price target from $8 to $10.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts